UPSIDE Foods Walks Away From $50M Bid for Believer Meats' North Carolina Plant
The termination leaves a $150 million cultivated-chicken facility without a buyer nine months after Believer Meats' collapse — a fresh reminder that cultivated meat's capital crunch has not eased, even for once-marquee assets.
What Happened
UPSIDE Foods has terminated its $50 million agreement to acquire the US production facility of distressed cultivated meat firm Believer Meats, according to court filings and a statement the company gave to AgFunderNews. The North Carolina Business Court had approved UPSIDE's asset purchase agreement in June as the baseline "stalking horse" bid, while advisory firm BDO Consulting Group marketed the assets in search of a higher offer.
No qualifying competing bids materialized by the deadline. Receiver Kevin Sink told the court that UPSIDE notified him it was exercising its termination right, and that as a result "the stalking horse bid no longer exists." The auction and sale hearing scheduled for mid-to-late August were both called off. Sink said he is now evaluating next steps for the sale process.
Key Takeaways
- UPSIDE Foods has terminated its $50M stalking-horse bid for Believer Meats' Wilson, North Carolina cultivated-chicken plant, but says it "remains interested in the facility."
- No competing bids exceeding the required $52.25M threshold were submitted before the deadline, leaving the receiver without a buyer.
- The $150M, 200,000 sq ft facility — USDA-approved in late 2025 for cultivated chicken — has sat idle for roughly nine months since Believer Meats ceased operations.
- Separately, an Israeli trustee is fielding bids for Believer Meats' underlying IP and technology from multiple parties across the cultivated meat industry.
- Secured creditors including Gray Construction ($36.4M claim) and Ameris Bank ($25M term loan) are first in line for any sale proceeds.
Why the Deal Fell Apart
Court documents from June set out several conditions under which UPSIDE could exit the agreement without penalty — including if the receiver breached the agreement, if required arrangements with creditors Gray Construction or GEA were not finalized in time, if UPSIDE could not confirm the facility would not infringe third-party intellectual property, or if the court failed to enter the necessary orders. UPSIDE's spokesperson framed the exit in similar terms, telling AgFunderNews: "the conditions of the transaction were not met, so we have exercised our termination right."
Notably, the company was explicit that its interest in the site has not disappeared. It says it will "evaluate next steps once the receiver outlines a new process and timeline" — language that leaves the door open to a renegotiated or restructured transaction rather than a clean walk-away.
The stalking horse bid no longer exists. No qualifying bids were received for the transferred assets by the final bid deadline.
Kevin Sink — Court-Appointed Receiver, filing to the North Carolina Business CourtA Facility Still Looking for a Home
The Wilson County plant is a well-specified asset by cultivated meat standards: 200,000 square feet, bioreactors reportedly at 20,000-litre scale, and USDA sign-off in November 2025 to manufacture cultivated chicken, with Believer Meats having stated the site's capacity could reach 26 million pounds annually. Built for roughly $150 million, it remains, for now, unused.
Believer Meats — formerly Future Meat Technologies, and one of the best-capitalized companies in the sector with close to $400 million raised from backers including ADM Ventures and Tyson Ventures — ceased operations in December after failing to meet a payment deadline tied to the facility's construction, and entered general receivership in February. Contractor Gray Construction has alleged it is owed $36.4 million for work on the site; Ameris Bank holds a $25 million secured term loan against Believer's equipment and accounts. Both sit ahead of any equity holders in the payout order.
Separately, the intellectual property behind Believer Meats' cultivated-meat process — its cell lines, media formulations and scale-up know-how — is being marketed independently by an Israeli trustee. That trustee told AgFunderNews he has received bids from multiple parties across the industry, suggesting the technology and the physical plant may ultimately end up with different buyers, or recombine under a future deal.
What This Signals for Cultivated Meat
The collapse of a second consecutive sale process for the same facility underscores how thin the buyer pool remains for distressed cultivated meat assets, even among peer companies with the technical know-how to use them. UPSIDE Foods itself framed its original bid as a way to accelerate its own production scale-up — evidence that even well-funded operators in the category are cautious about committing capital without conditions fully in their favor.
For the wider sector, the episode reinforces a pattern seen through 2025 and 2026: cultivated meat continues to notch regulatory milestones — Believer Meats itself became the fifth company approved to sell cultivated meat in the US just a month before it shut down — while struggling to convert that progress into durable financing and asset value. Investment into the category has retreated sharply from its 2021 peak, and hard infrastructure built during that boom, including purpose-built bioreactor facilities, is proving difficult to monetize even at steep discounts to construction cost.
MENA and Saudi Relevance
The Gulf has positioned itself as an active, if still early-stage, investor audience for alternative protein and cultivated meat technology. The UAE's AGWA food-tech hub in Abu Dhabi and a wave of Saudi and Gulf capital into agtech and novel-food ventures reflect a regional appetite to build local protein-production capability under Vision 2030 and the UAE's National Food Security Strategy 2051 — both responses to a region that imports the large majority of the red meat it consumes.
A distressed, fully-built US cultivated-meat facility changing hands — or failing to — is a relevant data point for Gulf investors and sovereign-linked funds evaluating opportunities in the space: it illustrates both the capital intensity of physical cultivated-meat infrastructure and the execution risk that has made even strategic buyers hesitant. For Saudi entities exploring direct investment, licensing, or technology-transfer routes into cultivated protein, cases like Believer Meats' liquidation may ultimately present opportunities to acquire proven infrastructure or IP at a fraction of original build cost — provided the legal and creditor complexities can be navigated.
SFT Editorial Analysis
This is not simply a story about one failed transaction — it is a signal about how cultivated meat capital is being reallocated industry-wide. Buyers with the technical capability to operate this kind of facility are still scarce, and even they are unwilling to close without every contingency resolved in their favor. For regional investors tracking the sector, the more durable opportunity may lie less in physical infrastructure and more in the underlying IP and process technology now being marketed separately — assets that carry lower capital intensity and can be deployed into new, purpose-built facilities rather than inherited liabilities.

